Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01184170 · ClinicalTrials.gov registry record · NA

Metabolically Normal and Metabolically Abnormal Obesity

A NA study, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
71
Enrollment target

NCT01184170 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 71 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01184170, a NA study, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
71 participants
Enrollment target

Study Summary

The purpose of this study is to learn more about why some obese persons are resistant to developing obesity-related metabolic diseases (such as diabetes and cardiovascular disease), while others are prone to developing these conditions. We will do this by studying obese persons before and after a 5% body weight gain. Subjects will be asked to increase their current diet for a period of 8-12 weeks in order to increase their current body weight by 5%. Each will then be asked to maintain this weight increase for 3 weeks. We will monitor subjects throughout this time period with weekly medical evaluations. At the completion of the study, we will provide each subject with a 6-month weight loss program.

Interventions

  • BEHAVIORAL overfeeding

Trial Details

FieldValue
Enrollment Target 71 participants
Start Date 2010-08
Est. Completion 2015-02
Phase NA

What the Registry Record Tells You About NCT01184170

The ClinicalTrials.gov registry entry for NCT01184170 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which overfeeding is the first listed.

NCT01184170 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01184170 about?

NCT01184170 is a clinical study titled "Metabolically Normal and Metabolically Abnormal Obesity". The purpose of this study is to learn more about why some obese persons are resistant to developing obesity-related metabolic diseases (such as diabetes and cardiovascular disease), while others are prone to developing these conditions. We will do this by studying obese persons before and after a 5%...

What is the current status of trial NCT01184170?

This trial is currently completed. It is a NA study. The enrollment target is 71 participants. The study started on 2010-08. Estimated completion is 2015-02.

What interventions are being tested in trial NCT01184170?

The interventions under investigation include: overfeeding (BEHAVIORAL).

Who is sponsoring clinical trial NCT01184170?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.